Jupiter Global Sustainable Equities Fund's Top Performers in Healthcare

Strategic Insights -

The Jupiter Global Sustainable Equities Fund, managed by Abbie Llewellyn-Waters, has excelled in the healthcare sector during the past year. The fund's focus on preventative healthcare and economically sustainable companies has led it to invest in top-performing brands such as CSL and Danaher. These companies have played a vital role in the battle against Covid-19, with CSL developing vaccines for various diseases and Danaher creating a test to diagnose Covid within 45 minutes. The fund has invested in these companies since the second quarter of 2018, driven by its commitment to supporting better patient outcomes, reducing healthcare costs, and promoting economic, environmental, and social sustainability.

Key Takeaways:

  • CSL, the top performer in the Jupiter Global Sustainable Equities portfolio during 2020, specializes in making antibodies-based products, including vaccines for diseases such as tetanus, MMR, and the flu.
  • CSL's subsidiary, Seqirus, is the main producer of Covid vaccines in Australia and has developed a potential plasmaderived therapy for treating Covid-19 in collaboration with Japan's Takeda Pharmaceutical.
  • Danaher, another top performer, developed a test to diagnose Covid within 45 minutes and is working on a single product that will differentiate between the flu and coronavirus.
  • Jupiter backs economically sustainable companies that focus on doing good for people, the planet, and profits, and invests in companies genuinely supporting better patient outcomes or reducing healthcare costs.
  • The fund's manager, Abbie Llewellyn-Waters, highlights CSL's 51% female participation in its workforce and its reinvestment in the business as key factors in its sustainable criteria.
  • Danaher's commitment to improving patient outcomes, such as its combined flu and Covid test, is another key aspect of Jupiter's investment strategy.
  • The company's acquisition of GE Biopharma for $21.4 billion demonstrates its willingness to expand its expertise in the biopharmaceutical sector.

Statistics:

  • CSL is the top performer in the Jupiter Global Sustainable Equities portfolio during 2020.
  • The fund invested in CSL and Danaher since the second quarter of 2018.
  • CSL has more than 51% female participation in its workforce.
  • Danaher has achieved 30 straight years of 100% cash conversion on a cash flow from operations net income perspective.

Sources:

  • Jupiter's Annual Report 2020
  • Abbie Llewellyn-Waters, manager of the Jupiter Global Sustainable Equities Fund
  • The article "The battle against Covid-19 has been a key theme in healthcare over the past year and two of the main players have had a vital role in the Jupiter Global Sustainable Equities Fund" by Marc Shoffman